Sorbus Advisors LLC

  • About
  • Services
    • Business Combinations
    • Financial Instruments
    • Credit Portfolio Valuations
    • Business Interests & 409A
  • Professionals
  • Resources
    • All
    • Financial Instruments
    • Portfolio Valuations
    • Business Interests
    • Business Combinations
  • Blog
  • Contact

BioPharmaceutical Valuations in Purchase Accounting

November 20, 2015   |   by Max Fonarev

Recent Posts

  • Covid-19 | Valuation Update | Three Months In
  • COVID-19 | Valuation Update
  • Valuing VC Investments – An Intuitive Example
  • Valuation Market Multiples: Not So Simple
  • Purchase Price Allocation (ASC 805) Benchmarking Study IT 2018

Labels

Fair Market Value Portfolio Valuation ASC 805 Financial Reporting Purchase Price Allocation Tax Compliance ASC 805 Purchase Accounting Fair Value Tax Valuation Transactions Business Interests Term Sheet Intangible Asset Valuation Life Sciences Purchase Accounting 409A Valuation IP Valuation Financial Instruments
  • Twitter
  • Linkedin
© 2021 Sorbus Advisors LLC. All Rights Reserved.   |   Terms of Use   |   Privacy Policy
Please leave your email address below to view this publication. By doing so, you consent to receive our quarterly newsletters. You can unsubscribe at any time.